scholarly journals MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transport

2022 ◽  
Vol 146 ◽  
pp. 112596
Author(s):  
Miguel Hueso ◽  
Raquel Griñán ◽  
Adrián Mallen ◽  
Estanislao Navarro ◽  
Elvira Purqueras ◽  
...  
2004 ◽  
Vol 173 (2) ◽  
pp. 197-202 ◽  
Author(s):  
Makoto Kinoshita ◽  
Mineko Fujita ◽  
Shinichi Usui ◽  
Yoko Maeda ◽  
Mikiko Kudo ◽  
...  

2022 ◽  
Vol 2022 ◽  
pp. 1-9
Author(s):  
Xiuting Xu ◽  
Zikai Song ◽  
Bao Mao ◽  
Guoliang Xu

Hyperlipidemia characterized by abnormal deposition of cholesterol in arteries can cause atherosclerosis and coronary artery occlusion, leading to atherosclerotic coronary heart disease. The body prevents atherosclerosis by reverse cholesterol transport to mobilize and excrete cholesterol and other lipids. Apolipoprotein A1, the major component of high-density lipoprotein, plays a key role in reverse cholesterol transport. Here, we reviewed the role of apolipoprotein A1-targeting molecules in antiatherosclerosis therapy, in particular ATP-binding cassette transporter A1, lecithin-cholesterol acyltransferase, and scavenger receptor class B type 1.


2001 ◽  
Vol 120 (5) ◽  
pp. A183
Author(s):  
Willem J.S. De Villiers ◽  
Ken Westherry ◽  
Yuna Kang ◽  
Eun Lee ◽  
Gary Varilek

2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
Tang-Bin Zou ◽  
Shan-Shan Zhu ◽  
Fei Luo ◽  
Wei-Qiao Li ◽  
Xue-Rong Sun ◽  
...  

High plasma level of HDL-cholesterol (HDL-C) has been consistently associated with a decreased risk of atherosclerosis (AS); thus, HDL-C is considered to be an antiatherogenic lipoprotein. The development of novel therapies to enhance the atheroprotective properties of HDL may have the possibility of further reducing the residual AS risk. Reverse cholesterol transport (RCT) is believed to be a primary atheroprotective activity of HDL, which has been shown to promote the efflux of excess cholesterol from macrophage-derived foam cells via ATP-binding cassette transporter A1 (ABCA1), ATP-binding cassette transporter G1 (ABCG1), and scavenger receptor class B type I (SR-BI) and then transport it back to the liver for excretion into bile and eventually into the feces. In the current study, we investigated the effects of astaxanthin on RCT and AS progression in mice. The results showed that short- and long-term supplementation of astaxanthin promote RCT in C57BL/6J and ApoE−/−mice, respectively. Moreover, astaxanthin can relieve the plaque area of the aortic sinus and aortic cholesterol in mice. These findings suggest that astaxanthin is beneficial for boosting RCT and preventing the development of AS.


Author(s):  
Naomi C Bernecic ◽  
Simon P Graaf ◽  
Tamara Leahy ◽  
Bart M Gadella

ABSTRACT Reverse Cholesterol Transport or cholesterol efflux is part of an extensive plasma membrane remodelling process in spermatozoa that is imperative for fertilisation. For ram spermatozoa, sheep serum is well known to support in vitro fertilisation (IVF), but knowledge of its explicit role is limited. Though, it is postulated to elicit cholesterol efflux owing to the presence of high density lipoproteins (HDLs) that interact with transmembrane cholesterol transporters, such as ATP-binding cassette transporter A1 (ABCA1) and scavenger receptor class B, type I (SR-BI). In this study, we report that both sheep serum and HDLs were able to elicit cholesterol efflux alone by up to 20–40% (as measured by the BODIPY-cholesterol assay). Furthermore, when the antagonists glibenclamide and valspodar were used to inhibit the function of ABCA1 and SR-BI or ABCA1 alone, respectively, cholesterol efflux was only marginally reduced (8–15)%. Nevertheless, it is likely that in ram spermatozoa, a specific facilitated pathway of cholesterol efflux is involved in the interaction between cholesterol acceptors and transporters. Interestingly, exposure to HDLs also induced hyperactivated motility, another critical event required for successful fertilisation. Taken together, this study details the first report of the dual action of HDLs on ram spermatozoa, providing both an insight into the intricacy of events leading up to fertilisation in vivo as well as demonstrating the possible application of HDL supplementation in media for IVF.


Hepatology ◽  
2013 ◽  
Vol 58 (1) ◽  
pp. 293-303 ◽  
Author(s):  
Arne Dikkers ◽  
Jan Freak de Boer ◽  
Wijtske Annema ◽  
Albert K. Groen ◽  
Uwe J.F. Tietge

2010 ◽  
Vol 1 (2) ◽  
pp. 174-187 ◽  
Author(s):  
Jason W. K. Goh ◽  
Yen Seah Tan ◽  
Alister W. Dodds ◽  
Kenneth B. M. Reid ◽  
Jinhua Lu

Author(s):  
Antonino Nicoletti ◽  
Giuseppina Caligiuri ◽  
Ingrid Törnberg ◽  
Tatsuhiko Kodama ◽  
Sten Stemme ◽  
...  

2011 ◽  
Vol 218 (2) ◽  
pp. 435-442 ◽  
Author(s):  
Pengzhi Dong ◽  
Tao Xie ◽  
Xiaoye Zhou ◽  
Wenquan Hu ◽  
Yuanli Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document